🔎 Trials Near Me

Почетна › Немалоклетни карцином плућа › Охајо › Cleveland

Kliničke studije za Немалоклетни карцином плућа u gradu Cleveland, OH

48 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u gradu Cleveland i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

Тражи се учесникФаза 1/2
  • Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07111520

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Тражи се учесникФаза 2/3
  • University Hospitals Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07100080

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Тражи се учесникФаза 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • UH Minoff Health Center at Chagrin Highlands, Orange · 12 ми удаљено
  • University Hospitals Seidman Cancer Center at UH Mentor Health Center, Mentor · 22 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06758401

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Тражи се учесникФаза 3
  • MetroHealth Medical Center, Cleveland
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • и још 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

Тражи се учесникФаза 1
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04886804

A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer

Тражи се учесникФаза 2
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06868485

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Тражи се учесникФаза 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • UH Minoff Health Center at Chagrin Highlands, Orange · 12 ми удаљено
  • University Hospitals Seidman Cancer Center at UH Mentor Health Center, Mentor · 22 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07144280

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Тражи се учесникФаза 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • Cleveland Clinic, Cleveland
  • Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07361497

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Тражи се учесникФаза 1
  • University Hospitals Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06465069

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Тражи се учесникФаза 3
  • Fairview Hospital, Cleveland
  • Cleveland Clinic, Cleveland
  • Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06890598

Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial

Тражи се учесникФаза 2
  • University Hospitals Seidman Cancer Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07746388

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

Тражи се учесникФаза 1/2
  • University Hospitals Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07397338

A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

Тражи се учесникФаза 1
  • UH Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07542704

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Тражи се учесникФаза 2
  • University Hospitals Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06667908

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Тражи се учесникФаза 1
  • Cleveland Clinic, Taussig Cancer Institute, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06720987

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

Тражи се учесникФаза 2/3
  • The Cleveland Clinic Cancer Center At Fairview Hospital, Moll Pavilion, Cleveland
  • Cleveland Clinic, Cleveland
  • Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06712316

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy

Тражи се учесникФаза 3
  • University Hospitals Cleveland Medical Center, Cleveland
Узраст од 18 до 90 · Оба пола · Ажурирано 2. 11. 2026. · NCT06745908

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Тражи се учесникФаза 2/3
  • University Hospitals Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT04613596

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Тражи се учесникФаза 1/2
  • University Hospitals Cleveland, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT05098132

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Тражи се учесникФаза 1
  • University Hospitals - UH Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT07094204

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Тражи се учесникФаза 1
  • Cleveland Clinic Taussig Cancer Institute, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06774963

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

Тражи се учесникФаза 1/2
  • Research Site, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06996782

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Тражи се учесник
  • Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT02984761

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Тражи се учесникФаза 2
  • Research Site, Cleveland
Узраст од 18 до 95 · Оба пола · Ажурирано 21. 10. 2026. · NCT05061550

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Тражи се учесникФаза 1/2
  • University Hospitals Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT06162221

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Тражи се учесникФаза 1/2
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT05786924

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Тражи се учесникФаза 1/2
  • Cleveland Clinic Taussig Cancer Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT07070232

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2/3
  • Louis Stokes Cleveland VA Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616584

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Тражи се учесникФаза 3
  • University Hospitals Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222566

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Тражи се учесникФаза 1/2
  • The Cleveland Clinic Taussig Cancer Center, Cleveland
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Тражи се учесникФаза 1
  • Exelixis Clinical Site #10, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT05176483

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 23. 9. 2026. · NCT06618287

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

Тражи се учесникФаза 2
  • University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT07104630

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Тражи се учесникФаза 3
  • Clinical Study Site, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT06767514

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Тражи се учесникОпсервациона студија
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT05059444

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Тражи се учесникФаза 1
  • University Hospital Cleveland Medical Center, Cleveland
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2026. · NCT06253871

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

Тражи се учесникФаза 1/2
  • Case Western Reserve University, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 4. 9. 2026. · NCT07012031

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Тражи се учесникФаза 1
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT06343402

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Тражи се учесникФаза 1
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT04913285

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Тражи се учесникФаза 1/2
  • Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 26. 8. 2026. · NCT06892548

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1
  • University Hospital - Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 5. 8. 2026. · NCT07444814

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Тражи се учесникФаза 1
  • University Hospitals Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT05208762

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1
  • Research Site, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 12. 6. 2026. · NCT07284186

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

Тражи се учесникФаза 2
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 8. 5. 2026. · NCT05363280

A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer

Тражи се учесникФаза 1/2
  • Gabrail Cancer Center, Ohio City · 1 ми удаљено
Узраст 19 и старији · Оба пола · Ажурирано 27. 4. 2026. · NCT07439094

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1/2
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 18. 2. 2026. · NCT07030257

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 ми удаљено
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

Тражи се учесникФаза 1/2
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 24. 10. 2025. · NCT06228326

Studije za Немалоклетни карцином плућа u drugim gradovima

Ostale studije u gradu Cleveland

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.